Estimation of adverse drug reaction reporting in Iran: Correction for underreporting.
Malahat KhaliliBita MesgarpourHamid SharifiAsieh GolozarAli Akbar HaghdoostPublished in: Pharmacoepidemiology and drug safety (2021)
The trend of ADRs reporting has been increasing over the 19 years but is still low. This study showed a considerable underreporting of ADR, and about one of four detected ADRs were reported to the pharmacovigilance center from 1999 to 2017.